BN Business News
会社を追加 →
この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。

規制と法律 · 1996/11/261 分で読めます

Intent to Grant an Exclusive License to SciClone Pharmaceuticals

ローカル自動翻訳 · 情報源の原言語

概要

In compliance with 37 CFR Sec. 404 et seq., the Department of the Army hereby gives notice of its intent to grant to SciClone Pharmaceuticals, a corporation having its principal place of business at 90 Mariner's Island Blvd., San Mateo, CA 94404, an exclusive license under U.S. Patent Applications Serial Numbers 07/878,372 filed 4 May 1992 and 08/145,660 filed 4 November 1993 respectively, and all continuations, continuations-in-part, divisionals, and reissues of the same, and all corresponding foreign patent applications which have been or will be filed. These applications relate to a composition for and a method of treating hepatitis C. Objections along with supporting evidence, if any, should be filed within 60 days from the date of this notice.

情報源の原言語: Federal Register — All Documents原文の発表を開く →

関連インサイト

ビジネスインサイト →